Clinical Trial Update: Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys? [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study at Oslo University Hospital evaluating whether dapagliflozin can preserve structure and function in transplante…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Kidney Transplant Failure
• Kidney Transplantation
• Renal Failure

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Kidney Transplant; Complications, Kidney Transplant Failure | Phase 4 | Status: RECRUITING